There was expected improvements made in second quarter to increase sales and reduce liabilities. However, now is the time for a letter to shareholders outlining how the five partners are doing with their products. Anticipated product launch of each partner, orders received, shipments made, etc. How goes the recovery RX that the 400 trained sales persons going? Overseas and domestic sales. Outlook for third and fourth quarter?